Lithuania, Oct. 14 -- Lithuania based UAB Tamro has secured contract from Ekstremaliu sveikatai situaciju centras prie SAM for Antibacterials for systemic use - EBOLA vakcina. The value of the contract is worth 699984 EUR.
Published by HT Digital Content Services with permission from Pivotal Sources....